RGC Share Price Performance
US$18.44
18.26 (10,055.42%)
Price US$18.44
Share PriceUS$18.44
Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation
Feb 21
Regencell Bioscience Holdings Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
RGC Community Narratives
There are no narratives available yet.
Recent RGC News & Updates
Regencell Bioscience Holdings Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0083
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Regencell Bioscience Holdings Limited Competitors
Snowflake Analysis
About RGC
- Founded
- 2014
- Employees
- 12
- CEO
- WebsiteView website
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Hong Kong Market Performance
- 7 Days: 0.09%
- 3 Months: 7.9%
- 1 Year: 31.5%
- Year to Date: 33.4%
In the last week, the market has stayed flat, however the Materials sector stood out, gaining 6.7%. As for the longer term, the market has risen 31% in the past 12 months. As for the next few years, earnings are expected to grow by 13% per annum. Market details ›